icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Quebec becomes latest to halt giving 1st doses of AstraZeneca’s Covid-19 jab in change to vaccine campaign

Quebec becomes latest to halt giving 1st doses of AstraZeneca’s Covid-19 jab in change to vaccine campaign
The Canadian province of Quebec will no longer offer AstraZeneca’s Covid-19 vaccine to people as a first dose, the health ministry has said, following advice on the issue from its immunization committee.

The ministry said in a statement on Thursday that almost all of its AstraZeneca doses have already been used in people aged 45 and over in recent weeks.

Any doses left, including an additional 148,000 set to arrive in the next week, will only be used as booster shots, the ministry said.

“I want to reassure Quebecers who received AstraZeneca in the first dose: its effectiveness is high and lasting,” Health Minister Christian Dubé said in a tweet on Thursday.

Also on rt.com Canada's Ontario province halts use of AstraZeneca's Covid-19 vaccine after risk of blood clots proves higher than expected

The ministry’s statement highlighted that blood clots related to AstraZeneca’s vaccine are a rare side effect – approximately 1 in 100,000 – but did not say this was the reason for its change in strategy.

Quebec is the latest Canadian province to alter its AstraZeneca vaccine use this week after Ontario suspended its rollout of the jab over blood clot concerns and Alberta paused its campaign due to supply issues.

Multiple countries around the world have reported a small number of unusual blood clotting cases among the millions of people injected with the Anglo-Swedish jab to date.

Drug regulators in the US and EU have said the vaccine's benefits continue to outweigh its risks.

Think your friends would be interested? Share this story!

Podcasts